ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,881.63
-0.43%
US Tech 100
20,449.60
-0.85%
Dow Jones
42,544.22
-0.07%
Brent Oil
73.855
-1.33%
Bitcoin
93,479.70
0.10%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Evaxion Biotech AS (EVAX)

  7. Evaxion Biotech AS (EVAX) News

EVAX

Evaxion Biotech AS (EVAX)

Evaxion Biotech AS
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EVAX
DateTimeSourceHeadlineSymbolCompany
12/30/20248:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/30/20248:00AMGlobeNewswire Inc.Evaxion announces plan to implement ADS ratio changeNASDAQ:EVAXEvaxion Biotech AS
12/26/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/17/20245:09PMEdgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:EVAXEvaxion Biotech AS
12/17/20248:16AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/17/20248:00AMGlobeNewswire Inc.Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equityNASDAQ:EVAXEvaxion Biotech AS
12/12/20248:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/12/20248:00AMGlobeNewswire Inc.Evaxion establishes new AI-derived precision cancer vaccine conceptNASDAQ:EVAXEvaxion Biotech AS
12/09/20249:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/09/20248:00AMGlobeNewswire Inc.Evaxion announces 2025 milestones reflecting continued strong strategy executionNASDAQ:EVAXEvaxion Biotech AS
12/05/20244:53PMEdgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:EVAXEvaxion Biotech AS
12/03/20246:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/02/20248:00AMGlobeNewswire Inc.Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology CongressNASDAQ:EVAXEvaxion Biotech AS
11/18/20244:30PMEdgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:EVAXEvaxion Biotech AS
11/13/20249:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
11/13/20248:00AMGlobeNewswire Inc.Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listingNASDAQ:EVAXEvaxion Biotech AS
11/13/20247:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
11/13/20247:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
11/12/20248:00AMGlobeNewswire Inc.Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1NASDAQ:EVAXEvaxion Biotech AS
10/31/202410:20AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
10/31/20248:00AMGlobeNewswire Inc.Evaxion announces business update and third quarter 2024 financial resultsNASDAQ:EVAXEvaxion Biotech AS
10/28/20249:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
10/28/20248:00AMGlobeNewswire Inc.Evaxion to announce business update and third quarter 2024 financial results on October 31NASDAQ:EVAXEvaxion Biotech AS
10/09/202411:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
10/09/20248:00AMGlobeNewswire Inc.Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trialsNASDAQ:EVAXEvaxion Biotech AS
10/04/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
10/03/20248:00AMGlobeNewswire Inc.Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platformNASDAQ:EVAXEvaxion Biotech AS
10/03/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
10/01/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
09/26/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
 Showing the most relevant articles for your search:NASDAQ:EVAX

Your Recent History

USOTC
ASII
Accredited Solutions (PK)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
CEOS
CeCors (PK)
NASDAQ
MULN
Mullen Automotive
NASDAQ
COOP
Mr Cooper
USOTC
MONI
Moon Equity (PK)
NASDAQ
TSLA
Tesla
USOTC
FNMA
Fannie Mae (QB)
USOTC
RDGL
Vivos (QB)
USOTC
AXXA
Exxe (PK)
USOTC
RNVA
Rennova Health (CE)
USOTC
HLLK
Hallmark Venture (PK)
USOTC
GTCH
GBT Technologies (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
BIEL
Bioelectronics (PK)
NASDAQ
ILLR
Triller
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads